While the individual sector has filled column inches recently for not selling as well as expected, the group critical illness market has shown signs of growth. Lucy Quinton reports Click here to download pdf
The group critical illness (CI) market has, surprisingly, not suffered a bout of depression over the past 12 months, but, instead, has enjoyed a fruitful year while its counterpart in the individual sector has made most of the headlines. According to the latest statistics by Swiss Re, premiums in force as of 31 December 2005 amounted to £28,191,708, while, 12 months later, the premiums totalled £34,798,472 – an increase of £6,606,764. The reinsurer's findings also show the number of schemes in effect as of 31 December 2006 as being 1,884. This is an increase from the previous year, which s...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes